Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY

Benzinga

11 Oct 2024

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growth

GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").

First Half of 2024 Financial Highlights

Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.
Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.
Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.
- Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2474109810"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2474109810\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2474109810?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-11 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474109810","market":"us","top_or_hot":-1,"title":"Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY","media":"Benzinga","content":"<html><body><p><i>Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth</i><i>Net income reached US$4.4 million, representing 85.8% year-over-year growth</i></p><p>GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- <a href=\"https://laohu8.com/S/BDMD\">Baird Medical Investment Holdings Ltd</a>. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").</p><p><strong>First Half of 2024 Financial Highlights</strong></p><ul><li>Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.</li><li>Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.</li><li>Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.<ul><li>Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.</li></ul></li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2024-10-11 20:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><i>Total revenues increased to US$13.1 million, representing 13.8% year-over-year growth</i><i>Net income reached US$4.4 million, representing 85.8% year-over-year growth</i></p><p>GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- <a href=\"https://laohu8.com/S/BDMD\">Baird Medical Investment Holdings Ltd</a>. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").</p><p><strong>First Half of 2024 Financial Highlights</strong></p><ul><li>Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.</li><li>Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.</li><li>Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.<ul><li>Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.</li></ul></li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BDMD","symbol_name":"百德医疗","start_time":0,"source_url":"https://www.benzinga.com/news/earnings/24/10/41289492/baird-medical-announces-preliminary-h1-revenue-results-of-13-1m-up-13-8-yoy","article_id":"2474109810","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474109810","pubTimestamp":1728648198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growthGUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BDMD":"百德医疗"},"translate_title":"Baird Medical公布上半年初步收入为1,310万美元，同比增长13.8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDMD":0.9},"content_text":"Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growthGUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) (\"Baird Medical\" or the \"Company\"), a leading microwave ablation (\"MWA\") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the \"First Half of 2024\").First Half of 2024 Financial HighlightsTotal revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}